Details
Original language | English |
---|---|
Patent number | AU2013282973A1 |
IPC | C07K7/64,G01N33/53 |
Priority date | 29 Jun 2012 |
Filing date | 28 Jun 2013 |
Publication status | Published - 5 Feb 2015 |
Abstract
This invention relates to the in vitro production of cyclic peptides using cyanobacterial enzymes, such as patellamide biosynthesis enzymes. Linear peptide substrates are cyclized using an isolated cyanbacterial macrocyclase, such as PatG from Prochloron spp. Before cyclisation, residues in the linear peptide substrates may be heterocyclised using isolated cyanbacterial heterocyclasses, such as PatD or TruD heterocyclase. Methods of the invention may be useful, for example, for the production of cyclic peptidyl molecules, including cyclotides, such as katalas, and cyanobactins, such as patellamides and telomestatins, for example for use in the development of therapeutics.
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
Patent No.: AU2013282973A1. Feb 05, 2015.
Research output: Patent
}
TY - PAT
T1 - In vitro production of cyclic peptides
AU - Ibrahim, Wael Houssen
AU - Jaspars, Marcel
AU - Smith, Margaret
AU - Naismith, James
AU - Koehnke, Jesko
AU - Bent, Andrew
AU - Westwood, Nicholas
PY - 2015/2/5
Y1 - 2015/2/5
N2 - This invention relates to the in vitro production of cyclic peptides using cyanobacterial enzymes, such as patellamide biosynthesis enzymes. Linear peptide substrates are cyclized using an isolated cyanbacterial macrocyclase, such as PatG from Prochloron spp. Before cyclisation, residues in the linear peptide substrates may be heterocyclised using isolated cyanbacterial heterocyclasses, such as PatD or TruD heterocyclase. Methods of the invention may be useful, for example, for the production of cyclic peptidyl molecules, including cyclotides, such as katalas, and cyanobactins, such as patellamides and telomestatins, for example for use in the development of therapeutics.
AB - This invention relates to the in vitro production of cyclic peptides using cyanobacterial enzymes, such as patellamide biosynthesis enzymes. Linear peptide substrates are cyclized using an isolated cyanbacterial macrocyclase, such as PatG from Prochloron spp. Before cyclisation, residues in the linear peptide substrates may be heterocyclised using isolated cyanbacterial heterocyclasses, such as PatD or TruD heterocyclase. Methods of the invention may be useful, for example, for the production of cyclic peptidyl molecules, including cyclotides, such as katalas, and cyanobactins, such as patellamides and telomestatins, for example for use in the development of therapeutics.
M3 - Patent
M1 - AU2013282973A1
Y2 - 2013/06/28
ER -